Ambea AB (ST:AMBEA) — Market Cap & Net Worth
Market Cap & Net Worth: Ambea AB (AMBEA)
Ambea AB (ST:AMBEA) has a market capitalization of $1.50 Billion (Skr13.98 Billion) as of September 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #7246 globally and #112 in its home market, demonstrating a 5.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ambea AB's stock price Skr174.50 by its total outstanding shares 80101290 (80.10 Million). Also see AMBEA current and non-current assets for a full breakdown of the balance sheet.
Ambea AB Market Cap History: 2017 to 2026
Ambea AB's market capitalization history from 2017 to 2026. Data shows growth from $505.24 Million to $1.50 Billion (10.89% CAGR). Also see cash flow conversion of Ambea AB for how efficiently the company converts equity into cash flow.
Ambea AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ambea AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Ambea AB for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.08x
Ambea AB's market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.83x
Ambea AB's market cap is 1.83 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $505.24 Million | $5.82 Billion | $226.00 Million | 0.09x | 2.24x |
| 2018 | $604.28 Million | $6.08 Billion | $295.00 Million | 0.10x | 2.05x |
| 2019 | $615.46 Million | $11.04 Billion | $215.00 Million | 0.06x | 2.86x |
| 2020 | $510.40 Million | $11.08 Billion | $359.00 Million | 0.05x | 1.42x |
| 2021 | $483.35 Million | $11.48 Billion | $237.00 Million | 0.04x | 2.04x |
| 2022 | $359.57 Million | $12.63 Billion | $366.00 Million | 0.03x | 0.98x |
| 2023 | $443.25 Million | $13.31 Billion | $455.00 Million | 0.03x | 0.97x |
| 2024 | $832.28 Million | $14.20 Billion | $620.00 Million | 0.06x | 1.34x |
| 2025 | $1.22 Billion | $16.04 Billion | $665.00 Million | 0.08x | 1.83x |
Competitor Companies of AMBEA by Market Capitalization
Companies near Ambea AB in the global market cap rankings as of September 19, 2026. Review AMBEA intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Ambea AB by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #289 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #915 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1235 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #289 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $429.04 |
| #915 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €46.12 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1235 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $261.90 |
Ambea AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Ambea AB's market cap moved from $505.24 Million to $ 1.50 Billion, with a yearly change of 10.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr1.50 Billion | +23.50% |
| 2025 | Skr1.22 Billion | +46.35% |
| 2024 | Skr832.28 Million | +87.77% |
| 2023 | Skr443.25 Million | +23.27% |
| 2022 | Skr359.57 Million | -25.61% |
| 2021 | Skr483.35 Million | -5.30% |
| 2020 | Skr510.40 Million | -17.07% |
| 2019 | Skr615.46 Million | +1.85% |
| 2018 | Skr604.28 Million | +19.60% |
| 2017 | Skr505.24 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Ambea AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.50 Billion USD |
| MoneyControl | $1.50 Billion USD |
| MarketWatch | $1.50 Billion USD |
| marketcap.company | $1.50 Billion USD |
| Reuters | $1.50 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ambea AB
Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments. The company offers social care services; schools for children and youth with neuropsychiatric disorders under the Nytida brand; nursing homes and home care services fo… Read more